First-line chemotherapy with planned sequential administration of gemcitabine (G) followed by docetaxel (D) in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study

Nsclc Patients ◽

P2-314: First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284022.90276.08 ◽

2007 ◽

Vol 2 (8) ◽

pp. S698

Author(s):

Carmelo Tibaldi ◽

Enrico Vasile ◽

Andrea Antonuzzo ◽

Roberta Di Marsico ◽

Gianna Tartarelli ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

Nsclc Patients ◽

1307 POSTER First-line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: a multicenter phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70733-4 ◽

2007 ◽

Vol 5 (4) ◽

pp. 176

Author(s):

C. Tibaldi ◽

E. Vasile ◽

M. Lo Dico ◽

A. Antonuzzo ◽

R. Di Marsico ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

Nsclc Patients ◽

First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly ‘unfrail’ patients with advanced non-small-cell lung cancer: a multicenter phase II study

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-012-1280-5 ◽

2012 ◽

Vol 138 (12) ◽

pp. 2003-2008 ◽

Cited By ~ 2

Author(s):

C. Tibaldi ◽

A. Camerini ◽

A. D’Incecco ◽

E. Vasile ◽

A. Fabbri ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

First Line Chemotherapy with Weekly Docetaxel and Cisplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer: A Multicenter Phase II Study

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181991d38 ◽

2009 ◽

Vol 4 (4) ◽

pp. 512-517 ◽

Cited By ~ 3

Author(s):

Keqi Han ◽

Weiguo Cao ◽

Jinfeng Che ◽

Shenxu Bo ◽

Xiaodong Guo ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Weekly Docetaxel ◽

Multicenter Phase ◽

Customized First Line Chemotherapy According to ERCC1 and RRM1 SNPS in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients: A Phase II Study

Annals of Oncology ◽

10.1016/s0923-7534(20)34208-3 ◽

2012 ◽

Vol 23 ◽

pp. ix528

Author(s):

F. Mazzoni ◽

G. Meoni ◽

F.L. Cecere ◽

C. Giuliani ◽

A. Camerini ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Nsclc Patients ◽

First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6604187 ◽

2008 ◽

Vol 98 (3) ◽

pp. 558-563 ◽

Cited By ~ 7

Author(s):

C Tibaldi ◽

E Vasile ◽

A Antonuzzo ◽

R Di Marsico ◽

A Fabbri ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Multicenter Phase ◽

Randomized Multicenter Phase II Study of Larotaxel (XRP9881) in Combination with Cisplatin or Gemcitabine as First-Line Chemotherapy in Nonirradiable Stage IIIB or Stage IV Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31817e6669 ◽

2008 ◽

Vol 3 (8) ◽

pp. 894-901 ◽

Cited By ~ 16

Author(s):

Petr Zatloukal ◽

Radj Gervais ◽

Johan Vansteenkiste ◽

Léon Bosquee ◽

Christiana Sessa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Multicenter Phase ◽

A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy

Lung Cancer ◽

10.1016/s0169-5002(02)00037-5 ◽

2002 ◽

Vol 37 (1) ◽

pp. 73-77 ◽

Cited By ~ 21

Author(s):

J.P. Sculier ◽

T. Berghmans ◽

J.J. Lafitte ◽

M. Richez ◽

P. Recloux ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

First Line ◽

Agent Treatment ◽

1325 A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients (75-years-old) with advanced non-squamous, non-small cell lung cancer

European Journal of Cancer ◽

10.1016/s0959-8049(16)30568-8 ◽

2015 ◽

Vol 51 ◽

pp. S196

Author(s):

M. Tamiya ◽

A. Tamiya ◽

H. Kaneda ◽

K. Nakagawa ◽

K. Goto ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90818-4 ◽

2003 ◽

Vol 1 (5) ◽

pp. S238 ◽

Cited By ~ 1

Author(s):

F. Cappuzzo ◽

S. Novello ◽

F. De Marinis ◽

M. Maur ◽

G. Scagliotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Nsclc Patients